FT-003 Clinical Trials
3 recruitingGenetic
Phase 13Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Gene Therapy for DME
Diabetic Macular Edema
Frontera Therapeutics78 enrolled1 locationNCT06492876
Recruiting
Phase 1Phase 2
Gene Therapy(FT-003) for Wet AMD
Neovascular Age-related Macular Degeneration
Frontera Therapeutics78 enrolled1 locationNCT06492863
Recruiting
Phase 1
Gene Therapy for Diabetic Macular Edema
Diabetic Macular Edema
Frontera Therapeutics18 enrolled1 locationNCT05916391